Form 4 for RGNX REGENXBIO Inc.
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001562180-22-004876 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-07 | 2022-06-03 | RGNX | Glucksmann Alexandra | Dir | A - Grant | $0.00 | +3,010 | 3,010 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | Glucksmann Alexandra | Dir | A - Grant | $0.00 | +15.3K | 15.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-03 | A | A | 3,010 | $0.00 | 3,010 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-03 | A | A | 15,324 | $0.00 | 15,324 | D | $22.84 · — to 2032-06-03 | 15,324 Common Stock | (F2) The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer. |